MannKind (MNKD) Earnings Date & Reports

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MNKD is expected to report earnings to fall 47.50% to 4 cents per share on May 07

Q1'25

Est.

$0.04

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.01

The last earnings report on February 26 showed earnings per share of 7 cents, beating the estimate of 2 cents. With 1.03M shares outstanding, the current market capitalization sits at 1.44B.

View a ticker or compare two or three

Compare

MNKD